Literature for peptidase C01.072: rhodesain
(Topics flags: S Structure, T Target, P Specificity, I Inhibitor, V Review. To select only the references relevant to a single topic, click the link above. See explanation.)
-
Sheu-Idrees,R., Marques,G.V.L., Santana,P.A.L., Diniz,L.A., Resende,D.M., Odoma,S., Olorunshola,O., Ferreira,R.S., Murta,S.M.F., Maltarollo,V.G. and de Oliveira,R.B.
Investigation of the activity of 4-aminoquinolines as cysteine protease inhibitors with application in the treatment of Chagas disease
Mem Inst Oswaldo Cruz120, e240161-e240161. PubMed Europe PubMed DOI I -
Di Chio,C., Starvaggi,J., Totaro,N., Previti,S., Natale,B., Cosconati,S., Bogacz,M., Schirmeister,T., Legac,J., Rosenthal,P.J., Zappala,M. and Ettari,R.
Development of Novel Peptidyl Nitriles Targeting Rhodesain and Falcipain-2 for the Treatment of Sleeping Sickness and Malaria
Int J Mol Sci25, PubMed Europe PubMed DOI I -
Ettari,R.
Cysteine Proteases as Validated Targets for the Treatment of Neglected and Poverty-Related Parasitic Diseases
Int J Mol Sci24, PubMed Europe PubMed DOI -
Di Chio,C., Previti,S., Amendola,G., Ravichandran,R., Wagner,A., Cosconati,S., Hellmich,U.A., Schirmeister,T., Zappala,M. and Ettari,R.
Development of novel dipeptide nitriles as inhibitors of rhodesain of Trypanosoma brucei rhodesiense
Eur J Med Chem236, 114328-114328. PubMed Europe PubMed DOI -
Elrufaie,H.A., Mohamed,L.M., Hamd,A.Y., Bala,N.A., Elbadawi,F.A., Ghaboosh,H. and Alzain,A.A.
Discovery of novel natural products as rhodesain inhibitors for human African trypanosomiasis using in silico techniques
J Biomol Struct Dyn1-13. PubMed Europe PubMed DOI -
Arafet,K., Gonzalez,F.V. and Moliner,V.
Elucidating the dual mode of action of dipeptidyl enoates in the inhibition of rhodesain cysteine proteases
Chemistry PubMed Europe PubMed DOI -
Barbosa da Silva,E., Rocha,D.A., Fortes,I.S., Yang,W., Monti,L., Siqueira-Neto,J.L., Caffrey,C.R., McKerrow,J., Andrade,S.F. and Ferreira,R.S.
Structure-Based Optimization of Quinazolines as Cruzain and TbrCATL Inhibitors
J Med Chem64, 13054-13071. PubMed Europe PubMed DOI I -
Di Chio,C., Previti,S., De Luca,F., Allegra,A., Zappala,M. and Ettari,R.
Drug combination studies of PS-1 and quercetin against rhodesain of Trypanosoma brucei rhodesiense
Nat Prod Res1-5. PubMed Europe PubMed DOI I -
Johe,P., Jung,S., Endres,E., Kersten,C., Zimmer,C., Ye,W., Sonnichsen,C., Hellmich,U.A., Sotriffer,C., Schirmeister,T. and Neuweiler,H.
Warhead Reactivity Limits the Speed of Inhibition of the Cysteine Protease Rhodesain
ACS Chem Biol16, 661-670. PubMed Europe PubMed DOI -
Johe,P., Jaenicke,E., Neuweiler,H., Schirmeister,T., Kersten,C. and Hellmich,U.A.
Structure, interdomain dynamics and pH-dependent autoactivation of pro-rhodesain, the main lysosomal cysteine protease from African trypanosomes
J Biol Chem100565-100565. PubMed Europe PubMed DOI -
Nakamura,Y., Hayashida,K., Delesalle,V., Qiu,Y., Omori,R., Simuunza,M., Sugimoto,C., Namangala,B. and Yamagishi,J.
Genetic Diversity of African Trypanosomes in Tsetse Flies and Cattle From the Kafue Ecosystem
Front Vet Sci8, 599815-599815. PubMed Europe PubMed DOI -
Santos Nascimento,I.J.D., de Aquino,T.M. and da Silva-Junior,E.F.
Cruzain and Rhodesain Inhibitors: Last Decade of Advances in Seeking for New Compounds Against American and African Trypanosomiases
Curr Top Med Chem PubMed Europe PubMed DOI V -
Alvarez,V.E., Iribarren,P.A., Niemirowicz,G.T. and Cazzulo,J.J.
Update on relevant trypanosome peptidases: Validated targets and future challenges
Biochim Biophys Acta Proteins Proteom1869, 140577-140577. PubMed Europe PubMed DOI -
Arafet,K., Gonzalez,F.V. and Moliner,V.
Quantum mechanics/molecular mechanics studies of the mechanism of cysteine proteases inhibition by dipeptidyl nitroalkenes
Chemistry26, 2002-2012. PubMed Europe PubMed DOI I -
da Costa,C.H.S., Bonatto,V., Dos Santos,A.M., Lameira,J., Leitao,A. and Montanari,C.A.
Evaluating QM/MM free energy surfaces for ranking cysteine protease covalent inhibitors
J Chem Inf Model60, 880-889. PubMed Europe PubMed DOI I -
Di Chio,C., Previti,S., Amendola,G., Cosconati,S., Schirmeister,T., Zappala,M. and Ettari,R.
Development of novel benzodiazepine-based peptidomimetics as inhibitors of rhodesain from Trypanosoma brucei rhodesiense
ChemMedChem15, 995-1001. PubMed Europe PubMed DOI I -
Ettari,R., Previti,S., Di Chio,C., Maiorana,S., Allegra,A., Schirmeister,T. and Zappala,M.
Drug synergism: studies of combination of RK-52 and curcumin against rhodesain of Trypanosoma brucei rhodesiense
ACS Med Chem Lett11, 806-810. PubMed Europe PubMed DOI I -
Klein,P., Barthels,F., Johe,P., Wagner,A., Tenzer,S., Distler,U., Le,T.A., Schmid,P., Engel,V., Engels,B., Hellmich,U.A., Opatz,T. and Schirmeister,T.
Naphthoquinones as covalent reversible inhibitors of cysteine proteases: studies on inhibition mechanism and kineticsNaphthoquinones as Covalent Reversible Inhibitors of Cysteine Proteases: Studies on Inhibition Mechanism and Kinetics
Molecules25, PubMed Europe PubMed DOI I -
Klein,P., Johe,P., Wagner,A., Jung,S., Kuhlborn,J., Barthels,F., Tenzer,S., Distler,U., Waigel,W., Engels,B., Hellmich,U.A., Opatz,T. and Schirmeister,T.
New cysteine protease inhibitors: electrophilic (het)arenes and unexpected prodrug identification for the Trypanosoma protease rhodesain
Molecules25, PubMed Europe PubMed DOI I -
Cianni,L., Feldmann,C.W., Gilberg,E., Gutschow,M., Juliano,L., Leitao,A., Bajorath,J. and Montanari,C.A.
Can cysteine protease cross-class inhibitors achieve selectivity?
J Med Chem62, 10497-10525. PubMed Europe PubMed DOI I -
Ettari,R., Previti,S., Maiorana,S., Allegra,A., Schirmeister,T., Grasso,S. and Zappala,M.
Drug combination studies of curcumin and genistein against rhodesain of Trypanosoma brucei rhodesiense
Nat Prod Res33, 3577-3581. PubMed Europe PubMed DOI I -
Santos,L.H., Waldner,B.J., Fuchs,J.E., Pereira,G.A.N., Liedl,K.R., Caffarena,E.R. and Ferreira,R.S.
Understanding structure-activity relationships for trypanosomal cysteine protease inhibitors by simulations and free energy calculations
J Chem Inf Model59, 137-148. PubMed Europe PubMed DOI I -
Steverding,D.
On the reversible and irreversible inhibition of rhodesain by curcumin
Molecules25, PubMed Europe PubMed DOI I -
Eyssen,L.E., Vather,P., Jackson,L., Ximba,P., Biteau,N., Baltz,T., Boulange,A., Buscher,P. and Coetzer,T.H.T.
Recombinant and native TviCATL from Trypanosoma vivax: enzymatic characterisation and evaluation as a diagnostic target for animal African trypanosomosis
Mol Biochem Parasitol223, 50-54. PubMed Europe PubMed DOI -
Giroud,M., Dietzel,U., Anselm,L., Banner,D., Kuglstatter,A., Benz,J., Blanc,J.B., Gaufreteau,D., Liu,H., Lin,X., Stich,A., Kuhn,B., Schuler,F., Kaiser,M., Brun,R., Schirmeister,T., Kisker,C., Diederich,F. and Haap,W.
Repurposing a library of human cathepsin L ligands: identification of macrocyclic lactams as potent rhodesain and Trypanosoma brucei inhibitors
J Med Chem61, 3350-3369. PubMed Europe PubMed DOI S I -
Giroud,M., Kuhn,B., Saint-Auret,S., Kuratli,C., Martin,R.E., Schuler,F., Diederich,F., Kaiser,M., Brun,R., Schirmeister,T. and Haap,W.
2 H-1,2,3-Triazole-based dipeptidyl nitriles: potent, selective, and trypanocidal rhodesain inhibitors by structure-based design
J Med Chem61, 3370-3388. PubMed Europe PubMed DOI I -
Macedo Koeller,C. and Bangs,J.D.
Processing and targeting of cathepsin L (TbCatL) to the lysosome in Trypanosoma brucei
Cell Microbiole12980-e12980. PubMed Europe PubMed DOI -
Rocha,D.A., Silva,E.B., Fortes,I.S., Lopes,M.S., Ferreira,R.S. and Andrade,S.F.
Synthesis and structure-activity relationship studies of cruzain and rhodesain inhibitors
Eur J Med Chem157, 1426-1459. PubMed Europe PubMed DOI I -
Royo,S., Schirmeister,T., Kaiser,M., Jung,S., Rodriguez,S., Bautista,J.M. and Gonzalez,F.V.
Antiprotozoal and cysteine proteases inhibitory activity of dipeptidyl enoates
Bioorg Med Chem26, 4624-4634. PubMed Europe PubMed DOI I -
Ferreira,L.G. and Andricopulo,A.D.
Targeting cysteine proteases in trypanosomatid disease drug discovery
Pharmacol Ther180, 49-61. PubMed Europe PubMed DOI T -
Giroud,M., Ivkovic,J., Martignoni,M., Fleuti,M., Trapp,N., Haap,W., Kuglstatter,A., Benz,J., Kuhn,B., Schirmeister,T. and Diederich,F.
Inhibition of the cysteine protease human cathepsin L by triazine nitriles: amide???heteroarene pi-stacking interactions and chalcogen bonding in the S3 pocket
ChemMedChem12, 257-270. PubMed Europe PubMed DOI I -
Previti,S., Ettari,R., Cosconati,S., Amendola,G., Chouchene,K., Wagner,A., Hellmich,U.A., Ulrich,K., Krauth-Siegel,R.L., Wich,P.R., Schmid,I., Schirmeister,T., Gut,J., Rosenthal,P.J., Grasso,S. and Zappala,M.
Development of novel peptide-based Michael acceptors targeting rhodesain and falcipain-2 for the treatment of neglected tropical diseases (NTDs)
J Med Chem60, 6911-6923. PubMed Europe PubMed DOI I -
Schirmeister,T., Schmitz,J., Jung,S., Schmenger,T., Krauth-Siegel,R.L. and Gutschow,M.
Evaluation of dipeptide nitriles as inhibitors of rhodesain, a major cysteine protease of Trypanosoma brucei
Bioorg Med Chem Lett27, 45-50. PubMed Europe PubMed DOI I -
Ettari,R., Previti,S., Cosconati,S., Kesselring,J., Schirmeister,T., Grasso,S. and Zappala,M.
Synthesis and biological evaluation of novel peptidomimetics as rhodesain inhibitors
J Enzyme Inhib Med Chem31, 1184-1191. PubMed Europe PubMed DOI I -
Ettari,R., Previti,S., Tamborini,L., Cullia,G., Grasso,S. and Zappala,M.
The inhibition of cysteine proteases rhodesain and TbCatB: a valuable approach to treat human African trypanosomiasis
Mini Rev Med Chem16, 1374-1391. PubMed Europe PubMed DOI V I -
Latorre,A., Schirmeister,T., Kesselring,J., Jung,S., Johe,P., Hellmich,U.A., Heilos,A., Engels,B., Krauth-Siegel,R.L., Dirdjaja,N., Bou-Iserte,L., Rodriguez,S. and Gonzalez,F.V.
Dipeptidyl nitroalkenes as potent reversible inhibitors of cysteine proteases rhodesain and cruzain
ACS Med Chem Lett7, 1073-1076. PubMed Europe PubMed DOI I -
Ettari,R., Pinto,A., Previti,S., Tamborini,L., Angelo,I.C., La Pietra,V., Marinelli,L., Novellino,E., Schirmeister,T., Zappala,M., Grasso,S., De Micheli,C. and Conti,P.
Development of novel dipeptide-like rhodesain inhibitors containing the 3-bromoisoxazoline warhead in a constrained conformation
Bioorg Med Chem23, 7053-7060. PubMed Europe PubMed DOI I -
Fonseca,N.C., da Cruz,L.F., da Silva Villela,F., do Nascimento Pereira,G.A., de Siqueira-Neto,J.L., Kellar,D., Suzuki,B.M., Ray,D., de Souza,T.B., Alves,R.J., Junior,P.A., Romanha,A.J., Murta,S.M., McKerrow,J.H., Caffrey,C.R., de Oliveira,R.B. and Ferreira,R.S.
Synthesis of a sugar-based thiosemicarbazone series and structure-activity relationship versus the parasite cysteine proteases rhodesain, cruzain, and Schistosoma mansoni cathepsin B1
Antimicrob Agents Chemother59, 2666-2677. PubMed Europe PubMed DOI I -
McShan,D., Kathman,S., Lowe,B., Xu,Z., Zhan,J., Statsyuk,A. and Ogungbe,I.V.
Identification of non-peptidic cysteine reactive fragments as inhibitors of cysteine protease rhodesain
Bioorg Med Chem Lett25, 4509-4512. PubMed Europe PubMed DOI I -
Royo,S., Rodriguez,S., Schirmeister,T., Kesselring,J., Kaiser,M. and Gonzalez,F.V.
Dipeptidyl enoates as potent rhodesain inhibitors that display a dual mode of action
ChemMedChem10, 1484-1487. PubMed Europe PubMed DOI I -
Alsford,S., Currier,R.B., Guerra-Assuncao,J.A., Clark,T.G. and Horn,D.
Cathepsin-L can resist lysis by human serum in Trypanosoma brucei brucei
PLoS Pathog10, e1004130-e1004130. PubMed Europe PubMed DOI -
Ettari,R., Pinto,A., Tamborini,L., Angelo,I.C., Grasso,S., Zappala,M., Capodicasa,N., Yzeiraj,L., Gruber,E., Aminake,M.N., Pradel,G., Schirmeister,T., De Micheli,C. and Conti,P.
Synthesis and biological evaluation of papain-family cathepsin L-like cysteine protease inhibitors containing a 1,4-benzodiazepine scaffold as antiprotozoal agents
ChemMedChem9, 1817-1825. PubMed Europe PubMed DOI I -
Ehmke,V., Winkler,E., Banner,D.W., Haap,W., Schweizer,W.B., Rottmann,M., Kaiser,M., Freymond,C., Schirmeister,T. and Diederich,F.
Optimization of triazine nitriles as rhodesain inhibitors: structure-activity relationships, bioisosteric imidazopyridine nitriles, and X-ray crystal structure analysis with human cathepsin L
ChemMedChem8, 967-975. PubMed Europe PubMed DOI I -
Elliott,E.B., McCarroll,D., Hasumi,H., Welsh,C.E., Panissidi,A.A., Jones,N.G., Rossor,C.L., Tait,A., Smith,G.L., Mottram,J.C., Morrison,L.J. and Loughrey,C.M.
Trypanosoma brucei cathepsin-L increases arrhythmogenic sarcoplasmic reticulum-mediated calcium release in rat cardiomyocytes
Cardiovasc Res100, 325-335. PubMed Europe PubMed DOI -
Ettari,R., Tamborini,L., Angelo,I.C., Micale,N., Pinto,A., De Micheli,C. and Conti,P.
Inhibition of rhodesain as a novel therapeutic modality for human African trypanosomiasis
J Med Chem56, 5637-5658. PubMed Europe PubMed DOI I -
Ettari,R., Tamborini,L., Angelo,I.C., Grasso,S., Schirmeister,T., Lo Presti,L., De Micheli,C., Pinto,A. and Conti,P.
Development of rhodesain inhibitors with a 3-bromoisoxazoline warhead
ChemMedChem8, 2070-2076. PubMed Europe PubMed DOI I -
Costa,T.F., Reis,F.C. and Lima,A.P.
Substrate inhibition and allosteric regulation by heparan sulfate of Trypanosoma brucei cathepsin L
Biochim Biophys Acta1824, 493-501. PubMed Europe PubMed DOI -
Ehmke,V., Quinsaat,J.E., Rivera-Fuentes,P., Heindl,C., Freymond,C., Rottmann,M., Brun,R., Schirmeister,T. and Diederich,F.
Tuning and predicting biological affinity: aryl nitriles as cysteine protease inhibitors
Org Biomol Chem10, 5764-5768. PubMed Europe PubMed DOI I -
Steverding,D., Sexton,D.W., Wang,X., Gehrke,S.S., Wagner,G.K. and Caffrey,C.R.
Trypanosoma brucei: chemical evidence that cathepsin L is essential for survival and a relevant drug target
Int J Parasitol42, 481-488. PubMed Europe PubMed DOI I -
Yang,P.Y., Wang,M., Li,L., Wu,H., He,C.Y. and Yao,S.Q.
Design, synthesis and biological evaluation of potent azadipeptide nitrile inhibitors and activity-based probes as promising anti-Trypanosoma brucei agents
Chemistry18, 6528-6541. PubMed Europe PubMed DOI I -
Caffrey,C.R., Lima,A.P. and Steverding,D.
Cysteine peptidases of kinetoplastid parasites
Adv Exp Med Biol712, 84-99. PubMed Europe PubMed DOI V -
Ehmke,V., Heindl,C., Rottmann,M., Freymond,C., Schweizer,W.B., Brun,R., Stich,A., Schirmeister,T. and Diederich,F.
Potent and selective inhibition of cysteine proteases from Plasmodium falciparum and Trypanosoma brucei
ChemMedChem6, 273-278. PubMed Europe PubMed DOI I -
Breuning,A., Degel,B., Schulz,F., Buchold,C., Stempka,M., Machon,U., Heppner,S., Gelhaus,C., Leippe,M., Leyh,M., Kisker,C., Rath,J., Stich,A., Gut,J., Rosenthal,P.J., Schmuck,C. and Schirmeister,T.
Michael acceptor based antiplasmodial and antitrypanosomal cysteine protease inhibitors with unusual amino acids
J Med Chem53, 1951-1963. PubMed Europe PubMed DOI I -
Ettari,R., Zappala,M., Micale,N., Schirmeister,T., Gelhaus,C., Leippe,M., Evers,A. and Grasso,S.
Synthesis of novel peptidomimetics as inhibitors of protozoan cysteine proteases falcipain-2 and rhodesain
Eur J Med Chem45, 3228-3233. PubMed Europe PubMed DOI I -
Kerr,I.D., Wu,P., Marion-Tsukamaki,R., Mackey,Z.B. and Brinen,L.S.
Crystal structures of TbCatB and rhodesain, potential chemotherapeutic targets and major cysteine proteases of Trypanosoma brucei
PLoS Negl Trop Dis4, e701-e701. PubMed Europe PubMed DOI S -
Mott,B.T., Ferreira,R.S., Simeonov,A., Jadhav,A., Ang,K.K., Leister,W., Shen,M., Silveira,J.T., Doyle,P.S., Arkin,M.R., McKerrow,J.H., Inglese,J., Austin,C.P., Thomas,C.J., Shoichet,B.K. and Maloney,D.J.
Identification and optimization of inhibitors of trypanosomal cysteine proteases: cruzain, rhodesain, and TbCatB
J Med Chem53, 52-60. PubMed Europe PubMed DOI S I -
Waag,T., Gelhaus,C., Rath,J., Stich,A., Leippe,M. and Schirmeister,T.
Allicin and derivates are cysteine protease inhibitors with antiparasitic activity
Bioorg Med Chem Lett20, 5541-5543. PubMed Europe PubMed DOI I -
Caffrey,C.R. and Steverding,D.
Kinetoplastid papain-like cysteine peptidases
Mol Biochem Parasitol167, 12-19. PubMed Europe PubMed DOI I -
Cortez,A.P., Rodrigues,A.C., Garcia,H.A., Neves,L., Batista,J.S., Bengaly,Z., Paiva,F. and Teixeira,M.M.
Cathepsin L-like genes of Trypanosoma vivax from Africa and South America - characterization, relationships and diagnostic implications
Mol Cell Probes23, 44-51. PubMed Europe PubMed DOI -
Kerr,I.D., Lee,J.H., Farady,C.J., Marion,R., Rickert,M., Sajid,M., Pandey,K.C., Caffrey,C.R., Legac,J., Hansell,E., McKerrow,J.H., Craik,C.S., Rosenthal,P.J. and Brinen,L.S.
Vinyl sulfones as antiparasitic agents and a structural basis for drug design
J Biol Chem284, 25697-25703. PubMed Europe PubMed DOI S I -
Steverding,D., Wang,X. and Sexton,D.W.
The trypanocidal effect of NO-releasing agents is not due to inhibition of the major cysteine proteinase in Trypanosoma brucei
Parasitol Res105, 1333-1338. PubMed Europe PubMed DOI -
Abdulla,M.H., O'Brien,T., Mackey,Z.B., Sajid,M., Grab,D.J. and McKerrow,J.H.
RNA interference of Trypanosoma brucei cathepsin B and L affects disease progression in a mouse model
PLoS Negl Trop Dis2, e298-e298. PubMed Europe PubMed DOI -
Jaishankar,P., Hansell,E., Zhao,D.M., Doyle,P.S., McKerrow,J.H. and Renslo,A.R.
Potency and selectivity of P2/P3-modified inhibitors of cysteine proteases from trypanosomes
Bioorg Med Chem Lett18, 624-628. PubMed Europe PubMed DOI I -
Mallari,J.P., Shelat,A., Kosinski,A., Caffrey,C.R., Connelly,M., Zhu,F., McKerrow,J.H. and Guy,R.K.
Discovery of trypanocidal thiosemicarbazone inhibitors of rhodesain and TbcatB
Bioorg Med Chem Lett18, 2883-2885. PubMed Europe PubMed DOI I -
Gonzalez,F.V., Izquierdo,J., Rodriguez,S., McKerrow,J.H. and Hansell,E.
Dipeptidyl-alpha,beta-epoxyesters as potent irreversible inhibitors of the cysteine proteases cruzain and rhodesain
Bioorg Med Chem Lett17, 6697-6700. PubMed Europe PubMed DOI I -
Reis,F.C., Costa,T.F., Sulea,T., Mezzetti,A., Scharfstein,J., Bromme,D., Menard,R. and Lima,A.P.
The propeptide of cruzipain - a potent selective inhibitor of the trypanosomal enzymes cruzipain and brucipain, and of the human enzyme cathepsin F
FEBS J274, 1224-1234. PubMed Europe PubMed DOI -
[YEAR:6-3-2006]Choe,Y., Leonetti,F., Greenbaum,D.C., Lecaille,F., Bogyo,M., Bromme,D., Ellman,J.A. and Craik,C.S.
Substrate profiling of cysteine proteases using a combinatorial peptide library identifies functionally unique specificities
J Biol Chem281, 12824-12832. PubMed Europe PubMed DOI P -
[YEAR:2-10-2006]Nikolskaia,O.V., de,A.L., Kim,Y.V., Lonsdale-Eccles,J.D., Fukuma,T., Scharfstein,J. and Grab,D.J.
Blood-brain barrier traversal by African trypanosomes requires calcium signaling induced by parasite cysteine protease
J Clin Invest116, 2739-2747. PubMed Europe PubMed DOI I -
[YEAR:1-3-2006]Vicik,R., Hoerr,V., Glaser,M., Schultheis,M., Hansell,E., McKerrow,J.H., Holzgrabe,U., Caffrey,C.R., Ponte-Sucre,A., Moll,H., Stich,A. and Schirmeister,T.
Aziridine-2,3-dicarboxylate inhibitors targeting the major cysteine protease of Trypanosoma brucei as lead trypanocidal agents
Bioorg Med Chem Lett16, 2753-2757. PubMed Europe PubMed DOI I -
[YEAR:3-1-2005]Fujii,N., Mallari,J.P., Hansell,E.J., Mackey,Z., Doyle,P., Zhou,Y.M., Gut,J., Rosenthal,P.J., McKerrow,J.H. and Guy,R.K.
Discovery of potent thiosemicarbazone inhibitors of rhodesain and cruzain
Bioorg Med Chem Lett15, 121-123. PubMed Europe PubMed DOI I -
[YEAR:10-2-2005]Gosalia,D.N., Salisbury,C.M., Ellman,J.A. and Diamond,S.L.
High throughput substrate specificity profiling of serine and cysteine proteases using solution-phase fluorogenic peptide microarrays
Mol Cell Proteomics4, 626-636. PubMed Europe PubMed DOI -
[YEAR:20-10-2003]Chiyanzu,I., Hansell,E., Gut,J., Rosenthal,P.J., McKerrow,J.H. and Chibale,K.
Synthesis and evaluation of isatins and thiosemicarbazone derivatives against cruzain, falcipain-2 and rhodesain
Bioorg Med Chem Lett13, 3527-3530. PubMed Europe PubMed DOI I -
Caffrey,C.R., Hansell,E., Lucas,K.D., Brinen,L.S., Hernandez,A.A., Cheng,J.N., Gwaltney,S.L., II, Roush,W.R., Stierhof,Y.D., Bogyo,M., Steverding,D. and McKerrow,J.H.
Active site mapping, biochemical properties and subcellular localization of rhodesain, the major cysteine protease of Trypanosoma brucei rhodesiense
Mol Biochem Parasitol118, 61-73. PubMed Europe PubMed DOI -
Scory,S., Caffrey,C.R., Stierhof,Y.D., Ruppel,A. and Steverding,D.
Trypanosoma brucei: killing of bloodstream forms in vitro and in vivo by the cysteine proteinase inhibitor Z-Phe-Ala-CHN2
Exp Parasitol91, 327-333. PubMed Europe PubMed DOI I -
Troeberg,L., Morty,R.E., Pike,R.N., Lonsdale-Eccles,J.D., Palmer,J.T., McKerrow,J.H. and Coetzer,T.H.
Cysteine proteinase inhibitors kill cultured bloodstream forms of Trypanosoma brucei brucei
Exp Parasitol91, 349-355. PubMed Europe PubMed DOI I -
Pamer,E.G., Davis,C.E. and So,M.
Expression and deletion analysis of the Trypanosoma brucei rhodesiense cysteine protease in Escherichia coli
Infect Immun59, 1074-1078. PubMed Europe PubMed -
Pamer,E.G., Davis,C.E., Eakin,A. and So,M.
Cloning and sequencing of the cysteine protease cDNA from Trypanosoma brucei rhodesiense
Nucleic Acids Res18, 6141-6141. PubMed Europe PubMed -
Mottram,J.C., North,M.J., Barry,J.D. and Coombs,G.H.
A cysteine proteinase cDNA from Trypanosoma brucei predicts an enzyme with an unusual C-terminal extension
FEBS Lett258, 211-215. PubMed Europe PubMed DOI
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2003
2001
1999
1991
1990
1989
